ArticleBrain tumor pathology2021

Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia.

Weiqi Dang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.